Skip to content

Covid19 – Continuity plan of the company INTEROR

INTEROR manufactures and sells very important and vital synthesis intermediates for the pharmaceutical industry.

In this difficult context we have implemented numerous measures to allow the continuity of production by minimizing as much as possible the risks incurred by our employees such as alternating shifts, delayed arrivals, etc., barrier gestures in compliance with the directives of the French government and the legal framework in force.

However, we plan to partially reduce our activity due to the work disrupted by the imposition of the various barriers and the time needed by the teams for regular disinfection.

Pharmaceutical intermediates will be maintained as a priority, aiming at a correct percentage of the initial order, but new orders for Q2 will not be accepted unless there is a health emergency.

However, we need all the support of our suppliers to provide the essential raw materials on our site, and of our partners to continue the necessary services entrusted by us, otherwise our activity would be slowed down.

We thank our suppliers for their involvement and our customers for their understanding in this unprecedented context.

Please do not hesitate to contact us for any further explanations.